
| Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection #MMPMID33691383Fiorcari S; Atene CG; Maffei R; Debbia G; Potenza L; Luppi M; Marasca RHaematologica 2021[Aug]; 106 (8): 2265-2268 PMID33691383show ga
?|*COVID-19[MESH]|*Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy[MESH]|Adenine/analogs & derivatives[MESH]|Humans[MESH]|Immunity, Innate[MESH]|Piperidines[MESH]|Protein Kinase Inhibitors[MESH]
  
DeepDyve Pubget Overpricing | 
|